Jacobson Pharma Corporation Limited (HKG:2633)

Market Cap	3.29B
Revenue (ttm)	1.58B
Net Income (ttm)	300.83M
Shares Out	1.99B
EPS (ttm)	0.15
PE Ratio	10.89
Forward PE	n/a
Dividend	0.11 (6.67%)
Ex-Dividend Date	Aug 11, 2025

Volume	796,000
Average Volume	1,352,052
Open	1.660
Previous Close	1.660
Day's Range	1.650 - 1.670
52-Week Range	0.560 - 1.780
Beta	0.30
RSI	56.34
Earnings Date	Aug 21, 2025

About HKG:2633

Jacobson Pharma Corporation Limited, through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally. It operates in two segments, Generic Drugs and Branded Healthcare. The company offers generic drugs for various therapeutic categories, including cardiovascular, central nervous, gastrointestinal, respiratory, musculo-skeletal, genito-urinary, anti-infectives, endocrine and metabolic, dermatological, and anti-allergic. It...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Employees: 1,749
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2633

Financial Performance

In 2024, HKG:2633's revenue was 1.58 billion, an increase of 7.43% compared to the previous year's 1.47 billion. Earnings were 300.83 million, an increase of 12.69%.